Provenance du réseau au premier degré de Denise Giangola Courbron
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 24 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Denise Giangola Courbron via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| IOMAI CORPORATION | Biotechnology | Founder Director of Finance/CFO Chief Operating Officer Director/Board Member | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Private Equity Investor | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Lehigh University | College/University | Undergraduate Degree Graduate Degree | |
| University of Virginia | College/University | Graduate Degree Graduate Degree | |
| Walter Reed Army Institute of Research | Corporate Officer/Principal Corporate Officer/Principal | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
ImmunoBiology Ltd.
 ImmunoBiology Ltd. BiotechnologyHealth Technology ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman | |
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Chairman | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| Whitman College | College/University | Undergraduate Degree | |
| Oral Roberts University | College/University | Doctorate Degree | |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree | |
| SUPERNUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Worcester Polytechnic Institute | College/University | Undergraduate Degree | |
| Johns Hopkins Bloomberg School of Public Health | College/University | Corporate Officer/Principal | |
Sanofi Pasteur, Inc.
 Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Pharmaceuticals: Major | President | |
Farmaprojects SA
 Farmaprojects SA Pharmaceuticals: MajorHealth Technology Farmaprojects SA provides regulatory affairs services to third party companies. The company was founded in 1988 and is headquartered in Barcelona, Spain. | Pharmaceuticals: Major | Chairman | |
| Stefan Forsberg Consulting AB | Corporate Officer/Principal | ||
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Pharmaceuticals: Generic | Chief Executive Officer | |
Cellastra, Inc.
 Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
| Galenos SRL | Director/Board Member | ||
| CANTARGIA AB | Pharmaceuticals: Major | Chairman | |
| MENDUS AB | Biotechnology | Director/Board Member | |
| Kabivitrum AB | Corporate Officer/Principal | ||
| Advet AB | Director/Board Member | ||
| GAVI Alliance (United States) | Investment Trusts/Mutual Funds | Director/Board Member | |
| Advet Production AB | Director/Board Member | ||
| Kabi Pharmacia | President | ||
Pharmacia Arzneimittel GmbH
 Pharmacia Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Pharmacia Arzneimittel GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ratingen, Germany. | Pharmaceuticals: Major | President | |
Kabipharmacia International
 Kabipharmacia International Pharmaceuticals: MajorHealth Technology Kabipharmacia International is a French company that manufactures pharmaceutical products. | Pharmaceuticals: Major | President | |
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Biotechnology | President | |
| JG Solutions Ltd. | Director/Board Member | ||
| European Vaccine Manufacturers | President | ||
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree | |
ICON Government & Public Health Solutions, Inc.
 ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Government & Public Health Solutions, Inc. operates as a full service Contract Research Organization (CRO) specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs, and devices. Its services include project, program, and data management; clinical monitoring; regulatory and medical affairs; and safety oversight and pharmacovigilance. The company was founded by Victoria Tifft in 1994 and is headquartered in Hinckley, OH. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 25 |
| Suède | 9 |
| Royaume-Uni | 7 |
| France | 4 |
| Autriche | 3 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 11 |
| Commercial Services | 3 |
| Miscellaneous | 2 |
Opérationnelle
| Director/Board Member | 67 |
| Corporate Officer/Principal | 56 |
| Independent Dir/Board Member | 21 |
| President | 20 |
| Undergraduate Degree | 19 |
Relations les plus connectées
| Insiders | |
|---|---|
| Gail Boudreaux | 30 |
| Sven Arne Andréasson | 24 |
| Rahul Singhvi | 22 |
| Fred Driscoll | 21 |
| Barclay Phillips | 16 |
| John A. Lambert | 13 |
| Mark C. Twyman | 10 |
| Richard Douglas | 10 |
| John Trizzino | 8 |
| Gregory Glenn | 7 |
| Amy B. Fix | 7 |
| James Cummings | 7 |
| Russell Wilson | 6 |
| Louis F. Fries | 6 |
| Jim Robinson | 6 |
- Bourse
- Insiders
- Denise Giangola Courbron
- Connexions Sociétés
